123 related articles for article (PubMed ID: 16343231)
1. What is the role of conservative primary surgical management of epithelial ovarian cancer: the United States experience and debate.
Monk BJ; Disaia PJ
Int J Gynecol Cancer; 2005; 15 Suppl 3():199-205. PubMed ID: 16343231
[TBL] [Abstract][Full Text] [Related]
2. Role of conservative surgery in ovarian cancer: the European experience.
Colombo N; Parma G; Lapresa MT; Maggi F; Piantanida P; Maggioni A
Int J Gynecol Cancer; 2005; 15 Suppl 3():206-11. PubMed ID: 16343232
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.
Schlaerth AC; Chi DS; Poynor EA; Barakat RR; Brown CL
Int J Gynecol Cancer; 2009 Oct; 19(7):1199-204. PubMed ID: 19823055
[TBL] [Abstract][Full Text] [Related]
4. Conservative management of epithelial ovarian cancer.
Dexeus S; Labastida R; Dexeus D
Eur J Gynaecol Oncol; 2005; 26(5):473-8. PubMed ID: 16285560
[TBL] [Abstract][Full Text] [Related]
5. The role of surgery in recurrent ovarian cancer.
Pfisterer J; Harter P; Canzler U; Richter B; Jackisch C; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Bois A; ;
Int J Gynecol Cancer; 2005; 15 Suppl 3():195-8. PubMed ID: 16343230
[TBL] [Abstract][Full Text] [Related]
6. Advances in treatment of epithelial ovarian cancer.
Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
[TBL] [Abstract][Full Text] [Related]
8. Survival and safety associated with aggressive surgery for stage III/IV epithelial ovarian cancer: A single institution observation study.
Tate S; Kato K; Nishikimi K; Matsuoka A; Shozu M
Gynecol Oncol; 2017 Oct; 147(1):73-80. PubMed ID: 28800941
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
[TBL] [Abstract][Full Text] [Related]
10. The role of primary debulking in advanced ovarian cancer patients.
Vlad C; Kubelac P; Alexandru I; Achimas-Cadariu P
J BUON; 2016; 21(5):1320. PubMed ID: 27837639
[No Abstract] [Full Text] [Related]
11. Borderline ovarian tumors and fertility.
Nam JH
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):227-34. PubMed ID: 20386444
[TBL] [Abstract][Full Text] [Related]
12. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of epithelial ovarian cancer: a review of the literature.
Dupont NC; Berman ML
Minerva Ginecol; 2004 Dec; 56(6):547-56. PubMed ID: 15729207
[TBL] [Abstract][Full Text] [Related]
14. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?
Larsen E; Blaakaer J
Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061
[TBL] [Abstract][Full Text] [Related]
15. Fertility after the treatment of gynecologic tumors.
Kesic V
Recent Results Cancer Res; 2008; 178():79-95. PubMed ID: 18080446
[TBL] [Abstract][Full Text] [Related]
16. Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Wang PH; Yuan CC; Shyong WY; Chiang SC; Chao JY; Yen MS; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):220-5. PubMed ID: 10746418
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
Li J; Wu X
Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
[TBL] [Abstract][Full Text] [Related]
19. Management of early-stage epithelial ovarian cancer.
Benjamin I; Rubin SC
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):107-19. PubMed ID: 8015759
[TBL] [Abstract][Full Text] [Related]
20. Results of conservative management of epithelial malignant and borderline ovarian tumours.
Morice P; Camatte S; Wicart-Poque F; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
Hum Reprod Update; 2003; 9(2):185-92. PubMed ID: 12751780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
